David Zaccardelli, President and CEO at Verona Pharma plc (VRNA), sold 911,072 shares at $2.58 ($2.4M) on 2023-05-01, disclosed to the SEC on 2023-05-03.
Scheduled sale ($2.4M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.58 | 455,536 | $1.2M | 50.0% |
| 2 | $2.58 | 455,536 | $1.2M | 50.0% |
| Total | $2.58 avg | 911,072 | $2.4M | 100% |
| Filing → |
| VRNA | SELL | 2025-05-29 | $7.1M | — | Filing → |
| VRNA | SELL | 2025-05-05 | $7.0M | — | Filing → |
| VRNA | SELL | 2025-05-01 | $1.6M | — | Filing → |